Further, it was demonstrated that PTPN11 is necessary for BCR::ABL1-induced hematologic neoplasms, as its deletion compromised induction of CML in mice (41). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.